Sorted By Test Name - Mayo Medical Laboratories

FNMR
91959
imaging (MRI) of pelvis, computed tomography (CT) scan, and pelvic and transvaginal ultrasound. The
detection of teratoma is dependent on age and ethnic background; the younger the patient, the less likely
that teratoma will be detected; black women are more likely to have teratoma than other ethnic groups.
Only 2% have a neoplasm other than ovarian teratoma. Neoplasms documented in women include breast
adenocarcinoma, ovarian neuroendocrine tumors, sex cord stromal tumor, pseudopapillary neoplasm of
pancreas, neuroblastoma, and Hodgkin lymphoma. Neoplasia has been documented in 5% of men:
testicular germ cell tumors or small-cell lung carcinoma. Simultaneous testing of serum and cerebrospinal
fluid (CSF) is recommended, because CSF is often more informative for NMDA-receptor antibody.
Useful For: Evaluating new onset encephalopathy (noninfectious or metabolic) comprising 1 or more
of the following: confusional states, psychosis, delirium, memory loss, hallucinations, movement
disorders, seizures, or hypoventilation Evaluating limbic encephalitis Directing a focused search for
cancer Investigating encephalopathy appearing in the course or wake of cancer therapy, and not
explainable by metastasis or drug effect
Interpretation: This is a valuable serological marker of autoimmune encephalopathy and of a patient's
immune response to cancer (usually teratoma). NMDA-receptor autoantibodies are usually accompanied
by subacute neurological symptoms and signs, and not found in healthy subjects.
Reference Values:
Negative
Clinical References: Dalmau J, Lancaster E, Martinez-Hernandez E, et al: Clinical experience and
laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74
NMR Lipoprofile
Reference Values:
Cardiovascular Disease Risk
HDL-P (total)______ umol/L
Low Risk: >34.9
Intermediate: 34.9-26.7
High Risk: